PARIS, July 29, 2016 /PRNewswire/ --

Sanofi, a global and diversified healthcare leader, reports results for the second quarter of 2016. CEO Olivier Brandicourt comments on the results.

Watch video interview and read transcript:

http://www.eurobusinessmedia.com/ceo-direct/sanofi/q2-2016-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire

Topics covered in the interview include:

• Q2 highlights
• Diabetes
• Praluent(R)
• Dengvaxia(R)
• CHC
• R&D
• Outlook

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

SOURCE Sanofi